Biodefense Specialists—Experts in Contamination Control
Ventum develops innovative air & space solutions for the future of hygiene
Our mission is to protect spaces against invisible threats, whether particulate, biological, chemical, or radioactive.
Ventum was founded to redefine the future of hygiene, biodefense, and environmental safety. Built on over three decades of technical expertise and field experience, we engineer sustainable solutions designed for the most demanding contamination challenges—and beyond.
We operate at the intersection of biotechnology, engineering, and environmental science, creating advanced systems to protect critical environments—from life sciences and biotech to high-security industrial sectors. Our technologies tackle biological, particulate, chemical, and radioactive threats with precision and purpose.
As we scale, we work with trusted partners and a multidisciplinary team of scientists, engineers, architects, and operators. Together, we’re building a cleaner, safer ecosystem, where breakthroughs in hygiene and biodefense support resilient industries, healthier communities, and sustainable progress.
For us, the future isn’t just clean, it’s intelligently clean. And we’re engineering it now.
Our commitment to sustainability
Our Executive Board
-
Gina Bandar
Chief Executive Officer
Gina is a trailblazing biotech and hygiene innovator and leader. Co-founder of Ventum, her expertise and network across France and the U.S. have been key to the company’s growth. She continues to drive advancements in biodefense and containment and technology.
-
John Murphy
Chief Financial Officer
John brings a wealth of expertise in financial strategy and investment management. After leaving UBS to launch his own ventures, he built a distinguished career across real estate, tech, and biotech. His work in complex financial landscapes drives his success.
-
Alex Kachou
Chief Technology Officer
Alex is a driving force behind Ventum’s technological and engineering progress. Shortly after pursuing a Mechanical Engineering degree from Worcester Polytechnic Institute, he established Ventum's US office, expanding the company’s global presence in biotech.
Our Scientific Advisory Board
-
Loutfi Kachou, PhD
Chief Scientific Officer
Dr. Kachou, a leading authority in biodefense and co-founder of Ventum, works with esteemed institutions like the French National Centre for Scientific Research (CNRS) and the National Aero-biological Surveillance Network (RNSA), while leading his pioneering microbiology lab.
-
Hervé Fleury, MD-PhD
Scientific Officer, Virology
Prof. Fleury, a virology expert and professor emeritus at the University of Bordeaux, co-founded an HIV unit with the WHO in 2009 and collaborated with Dr. Kachou on France’s BSL-4 laboratory. His contributions have advanced global virus tracking and virology research.
-
Laurent Mairot, MD–PharmD
Scientific Officer, Pharmacology
Dr. Mairot, Head Pharmacist at Aesio’s Beau-Soleil Clinic, combines expertise in hygiene and pharmacology to drive innovation and improve patient outcomes and safety. His work advances the integration of these fields, enhancing healthcare quality and operational efficiency.
-
Jean-Claude Teulade, PharmD-PhD
Scientific Officer, Biochemistry
Prof. Teulade, biochemistry professor emeritus at Clermont Ferrand Medical School, played a key role in developing Ventum One-Touch™. His expertise in antioxidants, anti-parasitics, and antivirals supports advancements in biochemistry and global health.
Strategic Alliances
